학술논문
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings
Document Type
Article
Author
Source
In: Journal of Antimicrobial Chemotherapy . (Journal of Antimicrobial Chemotherapy, 1 August 2023, 78(8):1882-1890)
Subject
Language
English
ISSN
14602091
03057453
03057453